These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15003330)

  • 21. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats.
    Fan F; Wierda D; Rozman KK
    Toxicology; 1996 Jan; 106(1-3):221-8. PubMed ID: 8571394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice.
    Fujimaki H; Nohara K; Kobayashi T; Suzuki K; Eguchi-Kasai K; Tsukumo S; Kijima M; Tohyama C
    Toxicol Sci; 2002 Mar; 66(1):117-24. PubMed ID: 11861978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: II. Effects on the pup and the adult.
    Gehrs BC; Riddle MM; Williams WC; Smialowicz RJ
    Toxicology; 1997 Oct; 122(3):229-40. PubMed ID: 9328223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
    Emond C; Birnbaum LS; DeVito MJ
    Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
    Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
    Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative sensitivities of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Cyp1a-1 and Cyp1a-2 gene expression and immunotoxicity in female B6C3F1 mice.
    Narasimhan TR; Craig A; Arellano L; Harper N; Howie L; Menache M; Birnbaum L; Safe S
    Fundam Appl Toxicol; 1994 Nov; 23(4):598-607. PubMed ID: 7867912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD.
    Mustafa A; Holladay SD; Goff M; Witonsky SG; Kerr R; Reilly CM; Sponenberg DP; Gogal RM
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):51-9. PubMed ID: 18534654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
    Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
    Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixture effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyl congeners in rats.
    Chu I; Lecavalier P; Håkansson H; Yagminas A; Valli VE; Poon P; Feeley M
    Chemosphere; 2001; 43(4-7):807-14. PubMed ID: 11372869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of cytochrome P450 isoenzymes after toxicokinetic interactions between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,2',4,4',5,5'-hexachlorobiphenyl in the liver of the mouse.
    De Jongh J; DeVito M; Nieboer R; Birnbaum L; Van den Berg M
    Fundam Appl Toxicol; 1995 May; 25(2):264-70. PubMed ID: 7665010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Kerkvliet NI; Brauner JA
    Environ Res; 1990 Aug; 52(2):146-54. PubMed ID: 2118453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Internal dose-effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in gonadotropin-primed weanling rat model.
    Shirota M; Kaneko T; Okuyama M; Sakurada Y; Shirota K; Matsuki Y
    Arch Toxicol; 2007 Apr; 81(4):261-9. PubMed ID: 17019562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha.
    Bryant PL; Schmid JE; Fenton SE; Buckalew AR; Abbott BD
    Toxicol Sci; 2001 Jul; 62(1):103-14. PubMed ID: 11399798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells.
    Kerkvliet NI; Oughton JA
    Toxicol Appl Pharmacol; 1993 Apr; 119(2):248-57. PubMed ID: 8480333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose- and time-dependent effects.
    Santostefano MJ; Wang X; Richardson VM; Ross DG; DeVito MJ; Birnbaum LS
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):294-310. PubMed ID: 9707506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of vitamin A and vitamin E succinate against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced body wasting, hepatomegaly, thymic atrophy, production of reactive oxygen species and DNA damage in C57BL/6J mice.
    Alsharif NZ; Hassoun EA
    Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):131-8. PubMed ID: 15447737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls.
    DeVito MJ; Ménache MG; Diliberto JJ; Ross DG; Birnbaum LS
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):157-72. PubMed ID: 10986007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.